Abstract
Curcuminoid-loaded lipid nanoparticles were produced by melt homogenization. The used lipid matrices were medium chain triglycerides, trimyristin (TM), and tristearin. The mean particle size of the preparations was between 130 and 180 nm. The incorporated curcuminoids revealed a good stability over a period of 12 months. The curcuminoid-loaded lipid nanoparticles were intended for the oral delivery of curcuminoids. Therefore, the fate of the triglyceride matrix in simulated gastric and simulated intestinal media under the influence of pepsin and pancreatin, respectively, was assessed. The degradation of the triglycerides was monitored by the pH–stat method and with high performance thin layer chromatography in connection with spectrodensitometry to quantify the different lipid fractions. The TM nanoparticles were not degraded in simulated gastric fluid (SGF), but the decomposition of the triglyceride matrix was rapid in the intestinal media. The digestion process was faster in the simulated fed state medium compared to the simulated fasted state medium. Additionally, the stability of the incorporated drug was tested in the respective physiological media. The curcuminoids showed an overall good stability in the different test media. The release of the curcuminoids from the lipid nanoparticles was determined by fluorescence imaging techniques. A slow release of the drug was found in phosphate buffer. In contrast, a more distinct release of the curcuminoids was verifiable in SGF and in simulated intestinal fluids. Overall, it was considered that the transfer of the drug into the outer media was mainly triggered by the lipid degradation and not by drug release.
Similar content being viewed by others
Abbreviations
- MCT:
-
Medium chain triglycerides
- MCT-NE:
-
MCT nanoemulsion
- TM:
-
Trimyristin
- TM-NE:
-
Trimyristin particles supercooled melt (nanoemulsion)
- TM-NS:
-
Trimyristin particles crystalline nanoparticles (nanosuspension)
- TS:
-
Tristearin
- TS-NS:
-
Tristearin nanoparticles
- TMCurc-NE:
-
Curcuminoid-loaded preparation
References
Abdalla A, Klein S, Mäder K (2008) A new self-emulsifying drug delivery system (SEDDS) for poorly soluble drugs: characterization, dissolution, in vitro digestion and incorporation into solid pellets. Eur J Pharm Sci 5:457–464
Aggarwal BB, Ichikawa H, Garodia P, Weerasinghe P, Sethi G, Bhatt ID, Pandey MK, Shishodia S et al (2006) From traditional Ayurvedic medicine to modern medicine: identification of therapeutic targets for suppression of inflammation and cancer. Exp Opin Ther Targets 1:87–118
Anand P, Kunnumakkara AB, Newman RA, Aggarwal BB (2007) Bioavailability of curcumin: problems and promises. Mol Pharm 6:807–818
Anand P, Sundaram C, Jhurani S, Kunnumakkara AB, Aggarwal BB (2008a) Curcumin and cancer: an “old-age” disease with an “age-old” solution. Cancer Lett 1:133–164
Anand P, Thomas SG, Kunnumakkara AB, Sundaram C, Harikumar KB, Sung B, Tharakan ST, Misra K et al (2008b) Biological activities of curcumin and its analogues (Congeners) made by man and Mother Nature. Biochem Pharmacol 11:1590–1611
Basniwal RK, Buttar HS, Jain VK, Jain N (2011) Curcumin nanoparticles: preparation, characterization, and antimicrobial study. J Agric Food Chem 59(5):2056–2061
Bauer E, Jakob S, Mosenthin R (2005) Principles of physiology of lipid digestion. Asian-Australas J Anim Sci 2:282–295
Bisht S, Feldmann G, Soni S, Ravi R, Karikar C, Maitra A, Maitra A (2007) Polymeric nanoparticle-encapsulated curcumin (“nanocurcumin”): a novel strategy for human cancer therapy. J Nanobiotechnol 5:3
Blümer C, Mäder K (2005) Isostatic ultra-high-pressure effects on supercooled melts in colloidal triglyceride dispersions. Pharm Res 10:1708–1715
Bonnaire L, Sandra S, Helgason T, Decker EA, Weiss J, McClements DJ (2008) Influence of lipid physical state on the in vitro digestibility of emulsified lipids. J Agric Food Chem 10:3791–3797
Boyd BJ (2003) Characterisation of drug release from cubosomes using the pressure ultrafiltration method. 1. Int J Pharm 2:239–247
Bunjes H, Koch MHJ, Westesen K (2000) Effect of particle size on colloidal solid triglycerides. Langmuir 12:5234–5241
Chirio D, Gallarate M, Trotta M, Carlotti M, Gaudino E, Cravotto G (2009) Influence of alpha- and gamma- cyclodextrin lipophilic derivatives on curcumin-loaded SLN. J Incl Phenom Macrocycl Chem 3:391–402
Compton DL, Vermillion KE, Laszlo JA (2007) Acyl migration kinetics of 2-monoacylglycerols from soybean oil via 1 H NMR. J Am Oil Chem Soc 4:343–348
Duvoix A, Blasius R, Delhalle S, Schnekenburger M, Morceau F, Henry E, Dicato M, Diederich M (2005) Chemopreventive and therapeutic effects of curcumin. Cancer Lett 2:181–190
Fernandez S, Jannin V, Rodier JD, Ritter N, Mahler B, Carrière F (2007) Comparative study on digestive lipase activities on the self emulsifying excipient Labrasol®, medium chain glycerides and PEG esters. Biochim Biophys Acta 5:633–640
Fernandez S, Rodier JD, Ritter N, Mahler B, Demarne F, Carrière F, Jannin V (2008) Lipolysis of the semi-solid self-emulsifying excipient Gelucire® 44/14 by digestive lipases. Biochim Biophys Acta 8:367–375
Fureby AM, Virto C, Adlercreutz P, Mattiasson B (1996) Acyl group migrations in 2-monoolein. Biocatal Biotransform 2:89–111
Golding M, Wooster TJ (2010) The influence of emulsion structure and stability on lipid digestion. Curr Opin Colloid Interface Sci 1–2:90–101
Gupta V, Aseh A, Ríos CN, Aggarwal BB, Mathur AB (2009) Fabrication and characterization of silk fibroin-derived curcumin nanoparticles for cancer therapy. Int J Nanomed 4:115–122
Kakkar V, Singh S, Singla D, Kaur IP (2011) Exploring solid lipid nanoparticles to enhance the oral bioavailability of curcumin. Mol Nutr Food Res 3:495–503
Kuntsche J, Mäder K (2010) Solid lipid nanoparticles (SLN) for drug delivery. Handbook Mater Nanomed 1:383–396
Levy MY, Benita S (1990) Drug release from submicronized o/w emulsion: a new in vitro kinetic evaluation model. Int J Pharm 1–3:29–37
Lukyanov AN, Torchilin VP (2004) Micelles from lipid derivatives of water-soluble polymers as delivery systems for poorly soluble drugs. Adv Drug Deliv Rev 9:1273–1289
McClements DJ, Li Y (2010) Structured emulsion-based delivery systems: controlling the digestion and release of lipophilic food components. Adv Colloid Interface Sci 2:213–228
Mehnert W, Mäder K (2001) Solid lipid nanoparticles: production, characterization and applications. Adv Drug Deliv Rev 2–3:165–196
Mukerjee A, Vishwanatha JK (2009) Formulation, characterization and evaluation of curcumin-loaded PLGA nanospheres for cancer therapy. Anticancer Res 10:3867–3875
Müller RH, Mehnert W, Lucks JS, Schwarz C, Zur Mühlen A, Meyhers H, Freitas C, Rühl D (1995) Solid lipid nanoparticles (SLN): an alternative colloidal carrier system for controlled drug delivery. Eur J Pharm Biopharm 1:62–69
Müller RH, Ruhl D, Runge SA (1996) Biodegradation of solid lipid nanoparticles as a function of lipase incubation time. Int J Pharm 1:115–121
Mun S, Decker EA, McClements DJ (2007) Influence of emulsifier type on in vitro digestibility of lipid droplets by pancreatic lipase. Food Res Int 6:770–781
Nguyen TH, Hanley T, Porter CJH, Boyd BJ (2011) Nanostructured liquid crystalline particles provide long duration sustained-release effect for a poorly water soluble drug after oral administration. J Controlled Release 2:180–186
Olbrich C, Müller RH (1999) Enzymatic degradation of SLN—effect of surfactant and surfactant mixtures. Int J Pharm 1:31–39
Olbrich C, Kayser O, Müller RH (2002a) Lipase degradation of Dynasan 114 and 116 solid lipid nanoparticles (SLN)—effect of surfactants, storage time and crystallinity. Int J Pharm 1–2:119–128
Olbrich C, Kayser O, Müller RH (2002b) Enzymatic degradation of dynasan 114 SLN—effect of surfactants and particle size. J Nanopart Res 1:121–129
Patton JS, Carey MC (1981) Inhibition of human pancreatic lipase-colipase activity by mixed bile salt-phospholipid micelles. Am J Physiol Gastrointest Liver Physiol 4:328–336
Porter CJH, Kaukonen AM, Taillardat Bertschinger A, Boyd BJ, O’Connor JM, Edwards GA, Charman WN (2004) Use of in vitro lipid digestion data to explain the in vivo performance of triglyceride based oral lipid formulations of poorly water soluble drugs: studies with halofantrine. J Pharm Sci 5:1110–1121
Priano L, Esposti D, Esposti R, Castagna G, De Medici C, Fraschini F, Gasco MR, Mauro A (2007) Solid lipid nanoparticles incorporating melatonin as new model for sustained oral and transdermal delivery systems. J Nanosci Nanotechnol 10:3596–3601
Ptak M, Egret-Charlier M, Sanson A, Bouloussa O (1980) A NMR study of the ionization of fatty acids, fatty amines and N-acylamino acids incorporated in phosphatidylcholine vesicles. Biochim Biophys Acta 2:387–397
Rosenblatt KM, Douroumis D, Bunjes H (2007) Drug release from differently structured monoolein/poloxamer nanodispersions studied with differential pulse polarography and ultrafiltration at low pressure. J Pharm Sci 6:1564–1575
Rübe A, Klein S, Mäder K (2006) Monitoring of in vitro fat digestion by electron paramagnetic resonance spectroscopy. Pharm Res 9:2024–2029
Sahu A, Bora U, Kasoju N, Goswami P (2008) Synthesis of novel biodegradable and self-assembling methoxy poly(ethylene glycol)-palmitate nanocarrier for curcumin delivery to cancer cells. Acta Biomater 6:1752–1761
Schädlich A, Rose C, Kuntsche J, Caysa H, Mueller T, Göpferich A, Mäder K (2011) How stealthy are PEG–PLA nanoparticles? An NIR in vivo study combined with detailed size measurements. Pharm Res 8:1–13
Shaikh J, Ankola DD, Beniwal V, Singh D, Kumar MNV (2009) Nanoparticle encapsulation improves oral bioavailability of curcumin by at least 9-fold when compared to curcumin administered with piperine as absorption enhancer. Eur J Pharm Sci 3–4:223–230
Small DM, Cabral DJ, Cistola DP, Parks JS, Hamilton JA (1984) The ionization behavior of fatty acids and bile acids in micelles and membranes. Hepatology S2:77S–79S
Tiyaboonchai W, Tungpradit W, Plianbangchang P (2007) Formulation and characterization of curcuminoids loaded solid lipid nanoparticles. Int J Pharm 1–2:299–306
Tønnesen HH, Karlsen J (1985) Studies on curcumin and curcuminoids. VI. Kinetics of curcumin degradation in aqueous solution. Z Lebensm Unters Forsch 5:402–404
Tønnesen HH, Másson M, Loftsson T (2002) Studies of curcumin and curcuminoids. XXVII. Cyclodextrin complexation: solubility, chemical and photochemical stability. Int J Pharm 1–2:127–135
Tuli R, Surmak A Jr, Herman JM (2011) Effect of diferuloyl methane (curcumin) on radiation-induced inhibition of proliferation and cytotoxicity of pancreatic cancer cells. J Clin Oncol 4:222
Wang YJ, Pan MH, Cheng AL, Lin LI, Ho YS, Hsieh CY, Lin JK (1997) Stability of curcumin in buffer solutions and characterization of its degradation products. J Pharm Biomed Anal 12:1867–1876
Washington C (1990) Drug release from microdisperse systems: a critical review. Int J Pharm 1:1–12
Washington C, Evans K (1995) Release rate measurements of model hydrophobic solutes from submicron triglyceride emulsions. J Controlled Release 3:383–390
Wulff-Pérez M, Gálvez-Ruíz MJ, De Vicente J, Martín-Rodríguez A (2010) Delaying lipid digestion through steric surfactant Pluronic F68: a novel in vitro approach. Food Res Int 6:1629–1633
Yang S, Zhu J, Lu Y, Liang B, Yang C (1999) Body distribution of camptothecin solid lipid nanoparticles after oral administration. Pharm Res 5:751–757
Youssef KM, El-Sherbeny MA (2005) Synthesis and antitumor activity of some curcumin analogs. Arch Pharm 4:181–189
Zangenberg NH, Müllertz A, Gjelstrup Kristensen H, Hovgaard L (2001a) A dynamic in vitro lipolysis model: II: evaluation of the model. Eur J Pharm Sci 3:237–244
Zangenberg NH, Müllertz A, Kristensen HG, Hovgaard L (2001b) A dynamic in vitro lipolysis model: I. Controlling the rate of lipolysis by continuous addition of calcium. Eur J Pharm Sci 2:115–122
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Noack, A., Oidtmann, J., Kutza, J. et al. In vitro digestion of curcuminoid-loaded lipid nanoparticles. J Nanopart Res 14, 1113 (2012). https://doi.org/10.1007/s11051-012-1113-0
Received:
Accepted:
Published:
DOI: https://doi.org/10.1007/s11051-012-1113-0